Insufficient number of patients

This retrospective, multi-center, chart review study will collect patient data from medical charts of pediatric patients who have been treated with Korlym for Cushing's syndrome.

This retrospective chart review study seeks to collect data from pediatric patients treated with Korlym (mifepristone) to help provide clinicians with some insight on the potential role of mifepristone in the treatment of pediatric patients with Cushing syndrome.

Only sites that have been identified to have patients appropriate for this protocol will be invited to participate and contribute data on their patients

Data to be collected from a retrospective chart review will include:

• Patient demographics
• Medical history
• Pre and post treatment clinical assessments and laboratory results
• Radiologic findings (if available)
• Adverse events

Data will be collected for all follow-up visits, up until the most recent encounter prior to IRB approval.

Inclusion Criteria:

• Pediatrics (age≤21 years) at time Korlym initiation
• Considered to have a diagnosis of endogenous Cushing's syndrome by the healthcare provider
• Received at least one dose of Korlym
• Availability of pre-treatment (baseline) and follow-up data

Exclusion Criteria:

• None

Pediatric patients who have been treated with Korlym for Cushing's syndrome